##gff-version 3
##sequence-region O15269 1 473
O15269	UniProtKB	Chain	1	473	.	.	.	ID=PRO_0000163853;Note=Serine palmitoyltransferase 1	
O15269	UniProtKB	Topological domain	1	15	.	.	.	Note=Lumenal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15269	UniProtKB	Transmembrane	16	36	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15269	UniProtKB	Topological domain	37	473	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O15269	UniProtKB	Modified residue	164	164	.	.	.	Note=Phosphotyrosine%3B by ABL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23629659;Dbxref=PMID:23629659	
O15269	UniProtKB	Alternative sequence	143	143	.	.	.	ID=VSP_043127;Note=In isoform 2. D->E;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O15269	UniProtKB	Alternative sequence	144	473	.	.	.	ID=VSP_043128;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O15269	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_011392;Note=In HSAN1A%3B inactive in the heterodimeric SPT complex%3B largely reduced activity with serine as substrate%2C but nearly no effect on serine affinity in the heterotrimeric SPT complex%3B in contrast to wild-type is able to use alanine as substrate leading to the formation of 1-deoxysphinganine (1-deoxySa)%3B does not interfere with SPT complex formation. C->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11242114,ECO:0000269|PubMed:19132419,ECO:0000269|PubMed:20504773,ECO:0000269|PubMed:22302274;Dbxref=dbSNP:rs119482082,PMID:11242114,PMID:19132419,PMID:20504773,PMID:22302274	
O15269	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_011393;Note=In HSAN1A%3B reduced activity%3B does not interfere with SPT complex formation. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11242114,ECO:0000269|PubMed:19132419;Dbxref=dbSNP:rs119482081,PMID:11242114,PMID:19132419	
O15269	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_011394;Note=In HSAN1A%3B present with both painful and painles phenotypes%3B reduced activity%3B does not interfere with SPT complex formation. V->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11242114,ECO:0000269|PubMed:19132419,ECO:0000269|PubMed:30420926;Dbxref=dbSNP:rs119482083,PMID:11242114,PMID:19132419,PMID:30420926	
O15269	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_037889;Note=R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17060578;Dbxref=dbSNP:rs45461899,PMID:17060578	
O15269	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_036610;Note=In a breast cancer sample%3B somatic mutation. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs542876370,PMID:16959974	
O15269	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_068476;Note=Found in a patient with HSAN1A%3B uncertain pathological significance. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22302274;Dbxref=dbSNP:rs768841574,PMID:22302274	
O15269	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_066245;Note=In HSAN1A%3B severe form with early onset%3B reduced activity. S->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19651702,ECO:0000269|PubMed:21618344,ECO:0000269|PubMed:24247255;Dbxref=dbSNP:rs267607087,PMID:19651702,PMID:21618344,PMID:24247255	
O15269	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_073294;Note=Probable disease-associated mutation found in severe HMSN%3B reduced activity. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23454272;Dbxref=dbSNP:rs267607087,PMID:23454272	
O15269	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_066246;Note=In HSAN1A%3B reduced activity. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19651702,ECO:0000269|PubMed:21618344;Dbxref=dbSNP:rs267607088,PMID:19651702,PMID:21618344	
O15269	UniProtKB	Natural variant	387	387	.	.	.	ID=VAR_037890;Note=Rare polymorphism%3B does not affect activity%3B does not interfere with SPT complex formation. G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15037712,ECO:0000269|PubMed:19132419;Dbxref=dbSNP:rs119482084,PMID:15037712,PMID:19132419	
O15269	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Increased serine palmitoyltransferase activity and sphingolipid content. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23629659;Dbxref=PMID:23629659	
